カテゴリー： Market Monitor Global, 世界, 医療/バイオ

非感染性前部ぶどう膜炎治療薬の世界市場見通し2023年-2029年

◆英語タイトル：Non-infectious Anterior Uveitis Treatment Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23JU5810）

◆商品コード：MMG23JU5810
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年6月
◆ページ数：79
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医薬品＆医療

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥494,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥642,200	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥741,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Non-infectious Anterior Uveitis Treatment Market 調査レポートは次の情報を含め、グローバルにおけるの非感染性前部ぶどう膜炎治療薬市場規模と予測を収録しています。・世界の非感染性前部ぶどう膜炎治療薬市場：売上、2018年-2023年、2024年-2029年
・世界の非感染性前部ぶどう膜炎治療薬市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の非感染性前部ぶどう膜炎治療薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「ステロイド薬」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

非感染性前部ぶどう膜炎治療薬のグローバル主要企業は、Bausch & Lomb、 Santen Pharmaceutical、 AbbVie、 OKYO、 Novartis、 Eyegate Pharmaceuticals、 Regeneron Pharmaceuticals、 Eyepoint pharmaceuticals、 Alimera Sciencesなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、非感染性前部ぶどう膜炎治療薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界の非感染性前部ぶどう膜炎治療薬市場：タイプ別、2018年-2023年、2024年-2029年
世界の非感染性前部ぶどう膜炎治療薬市場：タイプ別市場シェア、2022年
・ステロイド薬、免疫抑制薬、その他

世界の非感染性前部ぶどう膜炎治療薬市場：用途別、2018年-2023年、2024年-2029年
世界の非感染性前部ぶどう膜炎治療薬市場：用途別市場シェア、2022年
・病院、眼科、在宅医療、その他

世界の非感染性前部ぶどう膜炎治療薬市場：地域・国別、2018年-2023年、2024年-2029年
世界の非感染性前部ぶどう膜炎治療薬市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業における非感染性前部ぶどう膜炎治療薬のグローバル売上、2018年-2023年
・主要企業における非感染性前部ぶどう膜炎治療薬のグローバル売上シェア、2022年
・主要企業における非感染性前部ぶどう膜炎治療薬のグローバル販売量、2018年-2023年
・主要企業における非感染性前部ぶどう膜炎治療薬のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Bausch & Lomb、 Santen Pharmaceutical、 AbbVie、 OKYO、 Novartis、 Eyegate Pharmaceuticals、 Regeneron Pharmaceuticals、 Eyepoint pharmaceuticals、 Alimera Sciences

*************************************************************

・調査・分析レポートの概要
非感染性前部ぶどう膜炎治療薬市場の定義
市場セグメント
世界の非感染性前部ぶどう膜炎治療薬市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の非感染性前部ぶどう膜炎治療薬市場規模
世界の非感染性前部ぶどう膜炎治療薬市場規模：2022年 VS 2029年
世界の非感染性前部ぶどう膜炎治療薬市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの非感染性前部ぶどう膜炎治療薬の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の非感染性前部ぶどう膜炎治療薬製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：ステロイド薬、免疫抑制薬、その他
非感染性前部ぶどう膜炎治療薬のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、眼科、在宅医療、その他
非感染性前部ぶどう膜炎治療薬の用途別グローバル売上・予測

・地域別市場分析
地域別非感染性前部ぶどう膜炎治療薬市場規模 2022年と2029年
地域別非感染性前部ぶどう膜炎治療薬売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Bausch & Lomb、 Santen Pharmaceutical、 AbbVie、 OKYO、 Novartis、 Eyegate Pharmaceuticals、 Regeneron Pharmaceuticals、 Eyepoint pharmaceuticals、 Alimera Sciences
...

Uveitis is the third leading cause of blindness worldwide. The most common type of uveitis is an inflammation of the iris called iritis (anterior uveitis). Uveitis can damage vital eye tissue, leading to permanent vision loss.
This report aims to provide a comprehensive presentation of the global market for Non-infectious Anterior Uveitis Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non-infectious Anterior Uveitis Treatment. This report contains market size and forecasts of Non-infectious Anterior Uveitis Treatment in global, including the following market information:
Global Non-infectious Anterior Uveitis Treatment Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Non-infectious Anterior Uveitis Treatment Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Non-infectious Anterior Uveitis Treatment companies in 2022 (%)
The global Non-infectious Anterior Uveitis Treatment market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Corticosteroid Drug Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Non-infectious Anterior Uveitis Treatment include Bausch & Lomb, Santen Pharmaceutical, AbbVie, OKYO, Novartis, Eyegate Pharmaceuticals, Regeneron Pharmaceuticals, Eyepoint pharmaceuticals and Alimera Sciences, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Non-infectious Anterior Uveitis Treatment manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Non-infectious Anterior Uveitis Treatment Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Non-infectious Anterior Uveitis Treatment Market Segment Percentages, by Type, 2022 (%)
Corticosteroid Drug
Immunosuppressant Drug
Others
Global Non-infectious Anterior Uveitis Treatment Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Non-infectious Anterior Uveitis Treatment Market Segment Percentages, by Application, 2022 (%)
Hospitals
Eye Clinics
Home Treatment
Others
Global Non-infectious Anterior Uveitis Treatment Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Non-infectious Anterior Uveitis Treatment Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Non-infectious Anterior Uveitis Treatment revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Non-infectious Anterior Uveitis Treatment revenues share in global market, 2022 (%)
Key companies Non-infectious Anterior Uveitis Treatment sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Non-infectious Anterior Uveitis Treatment sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bausch & Lomb
Santen Pharmaceutical
AbbVie
OKYO
Novartis
Eyegate Pharmaceuticals
Regeneron Pharmaceuticals
Eyepoint pharmaceuticals
Alimera Sciences
Outline of Major Chapters:
Chapter 1: Introduces the definition of Non-infectious Anterior Uveitis Treatment, market overview.
Chapter 2: Global Non-infectious Anterior Uveitis Treatment market size in revenue and volume.
Chapter 3: Detailed analysis of Non-infectious Anterior Uveitis Treatment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Non-infectious Anterior Uveitis Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Non-infectious Anterior Uveitis Treatment capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Non-infectious Anterior Uveitis Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Non-infectious Anterior Uveitis Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Non-infectious Anterior Uveitis Treatment Overall Market Size
2.1 Global Non-infectious Anterior Uveitis Treatment Market Size: 2022 VS 2029
2.2 Global Non-infectious Anterior Uveitis Treatment Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Non-infectious Anterior Uveitis Treatment Sales: 2018-2029
3 Company Landscape
3.1 Top Non-infectious Anterior Uveitis Treatment Players in Global Market
3.2 Top Global Non-infectious Anterior Uveitis Treatment Companies Ranked by Revenue
3.3 Global Non-infectious Anterior Uveitis Treatment Revenue by Companies
3.4 Global Non-infectious Anterior Uveitis Treatment Sales by Companies
3.5 Global Non-infectious Anterior Uveitis Treatment Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Non-infectious Anterior Uveitis Treatment Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Non-infectious Anterior Uveitis Treatment Product Type
3.8 Tier 1, Tier 2 and Tier 3 Non-infectious Anterior Uveitis Treatment Players in Global Market
3.8.1 List of Global Tier 1 Non-infectious Anterior Uveitis Treatment Companies
3.8.2 List of Global Tier 2 and Tier 3 Non-infectious Anterior Uveitis Treatment Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Non-infectious Anterior Uveitis Treatment Market Size Markets, 2022 & 2029
4.1.2 Corticosteroid Drug
4.1.3 Immunosuppressant Drug
4.1.4 Others
4.2 By Type – Global Non-infectious Anterior Uveitis Treatment Revenue & Forecasts
4.2.1 By Type – Global Non-infectious Anterior Uveitis Treatment Revenue, 2018-2023
4.2.2 By Type – Global Non-infectious Anterior Uveitis Treatment Revenue, 2024-2029
4.2.3 By Type – Global Non-infectious Anterior Uveitis Treatment Revenue Market Share, 2018-2029
4.3 By Type – Global Non-infectious Anterior Uveitis Treatment Sales & Forecasts
4.3.1 By Type – Global Non-infectious Anterior Uveitis Treatment Sales, 2018-2023
4.3.2 By Type – Global Non-infectious Anterior Uveitis Treatment Sales, 2024-2029
4.3.3 By Type – Global Non-infectious Anterior Uveitis Treatment Sales Market Share, 2018-2029
4.4 By Type – Global Non-infectious Anterior Uveitis Treatment Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Non-infectious Anterior Uveitis Treatment Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Eye Clinics
5.1.4 Home Treatment
5.1.5 Others
5.2 By Application – Global Non-infectious Anterior Uveitis Treatment Revenue & Forecasts
5.2.1 By Application – Global Non-infectious Anterior Uveitis Treatment Revenue, 2018-2023
5.2.2 By Application – Global Non-infectious Anterior Uveitis Treatment Revenue, 2024-2029
5.2.3 By Application – Global Non-infectious Anterior Uveitis Treatment Revenue Market Share, 2018-2029
5.3 By Application – Global Non-infectious Anterior Uveitis Treatment Sales & Forecasts
5.3.1 By Application – Global Non-infectious Anterior Uveitis Treatment Sales, 2018-2023
5.3.2 By Application – Global Non-infectious Anterior Uveitis Treatment Sales, 2024-2029
5.3.3 By Application – Global Non-infectious Anterior Uveitis Treatment Sales Market Share, 2018-2029
5.4 By Application – Global Non-infectious Anterior Uveitis Treatment Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Non-infectious Anterior Uveitis Treatment Market Size, 2022 & 2029
6.2 By Region – Global Non-infectious Anterior Uveitis Treatment Revenue & Forecasts
6.2.1 By Region – Global Non-infectious Anterior Uveitis Treatment Revenue, 2018-2023
6.2.2 By Region – Global Non-infectious Anterior Uveitis Treatment Revenue, 2024-2029
6.2.3 By Region – Global Non-infectious Anterior Uveitis Treatment Revenue Market Share, 2018-2029
6.3 By Region – Global Non-infectious Anterior Uveitis Treatment Sales & Forecasts
6.3.1 By Region – Global Non-infectious Anterior Uveitis Treatment Sales, 2018-2023
6.3.2 By Region – Global Non-infectious Anterior Uveitis Treatment Sales, 2024-2029
6.3.3 By Region – Global Non-infectious Anterior Uveitis Treatment Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Non-infectious Anterior Uveitis Treatment Revenue, 2018-2029
6.4.2 By Country – North America Non-infectious Anterior Uveitis Treatment Sales, 2018-2029
6.4.3 US Non-infectious Anterior Uveitis Treatment Market Size, 2018-2029
6.4.4 Canada Non-infectious Anterior Uveitis Treatment Market Size, 2018-2029
6.4.5 Mexico Non-infectious Anterior Uveitis Treatment Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Non-infectious Anterior Uveitis Treatment Revenue, 2018-2029
6.5.2 By Country – Europe Non-infectious Anterior Uveitis Treatment Sales, 2018-2029
6.5.3 Germany Non-infectious Anterior Uveitis Treatment Market Size, 2018-2029
6.5.4 France Non-infectious Anterior Uveitis Treatment Market Size, 2018-2029
6.5.5 U.K. Non-infectious Anterior Uveitis Treatment Market Size, 2018-2029
6.5.6 Italy Non-infectious Anterior Uveitis Treatment Market Size, 2018-2029
6.5.7 Russia Non-infectious Anterior Uveitis Treatment Market Size, 2018-2029
6.5.8 Nordic Countries Non-infectious Anterior Uveitis Treatment Market Size, 2018-2029
6.5.9 Benelux Non-infectious Anterior Uveitis Treatment Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Non-infectious Anterior Uveitis Treatment Revenue, 2018-2029
6.6.2 By Region – Asia Non-infectious Anterior Uveitis Treatment Sales, 2018-2029
6.6.3 China Non-infectious Anterior Uveitis Treatment Market Size, 2018-2029
6.6.4 Japan Non-infectious Anterior Uveitis Treatment Market Size, 2018-2029
6.6.5 South Korea Non-infectious Anterior Uveitis Treatment Market Size, 2018-2029
6.6.6 Southeast Asia Non-infectious Anterior Uveitis Treatment Market Size, 2018-2029
6.6.7 India Non-infectious Anterior Uveitis Treatment Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Non-infectious Anterior Uveitis Treatment Revenue, 2018-2029
6.7.2 By Country – South America Non-infectious Anterior Uveitis Treatment Sales, 2018-2029
6.7.3 Brazil Non-infectious Anterior Uveitis Treatment Market Size, 2018-2029
6.7.4 Argentina Non-infectious Anterior Uveitis Treatment Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Non-infectious Anterior Uveitis Treatment Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Non-infectious Anterior Uveitis Treatment Sales, 2018-2029
6.8.3 Turkey Non-infectious Anterior Uveitis Treatment Market Size, 2018-2029
6.8.4 Israel Non-infectious Anterior Uveitis Treatment Market Size, 2018-2029
6.8.5 Saudi Arabia Non-infectious Anterior Uveitis Treatment Market Size, 2018-2029
6.8.6 UAE Non-infectious Anterior Uveitis Treatment Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Bausch & Lomb
7.1.1 Bausch & Lomb Company Summary
7.1.2 Bausch & Lomb Business Overview
7.1.3 Bausch & Lomb Non-infectious Anterior Uveitis Treatment Major Product Offerings
7.1.4 Bausch & Lomb Non-infectious Anterior Uveitis Treatment Sales and Revenue in Global (2018-2023)
7.1.5 Bausch & Lomb Key News & Latest Developments
7.2 Santen Pharmaceutical
7.2.1 Santen Pharmaceutical Company Summary
7.2.2 Santen Pharmaceutical Business Overview
7.2.3 Santen Pharmaceutical Non-infectious Anterior Uveitis Treatment Major Product Offerings
7.2.4 Santen Pharmaceutical Non-infectious Anterior Uveitis Treatment Sales and Revenue in Global (2018-2023)
7.2.5 Santen Pharmaceutical Key News & Latest Developments
7.3 AbbVie
7.3.1 AbbVie Company Summary
7.3.2 AbbVie Business Overview
7.3.3 AbbVie Non-infectious Anterior Uveitis Treatment Major Product Offerings
7.3.4 AbbVie Non-infectious Anterior Uveitis Treatment Sales and Revenue in Global (2018-2023)
7.3.5 AbbVie Key News & Latest Developments
7.4 OKYO
7.4.1 OKYO Company Summary
7.4.2 OKYO Business Overview
7.4.3 OKYO Non-infectious Anterior Uveitis Treatment Major Product Offerings
7.4.4 OKYO Non-infectious Anterior Uveitis Treatment Sales and Revenue in Global (2018-2023)
7.4.5 OKYO Key News & Latest Developments
7.5 Novartis
7.5.1 Novartis Company Summary
7.5.2 Novartis Business Overview
7.5.3 Novartis Non-infectious Anterior Uveitis Treatment Major Product Offerings
7.5.4 Novartis Non-infectious Anterior Uveitis Treatment Sales and Revenue in Global (2018-2023)
7.5.5 Novartis Key News & Latest Developments
7.6 Eyegate Pharmaceuticals
7.6.1 Eyegate Pharmaceuticals Company Summary
7.6.2 Eyegate Pharmaceuticals Business Overview
7.6.3 Eyegate Pharmaceuticals Non-infectious Anterior Uveitis Treatment Major Product Offerings
7.6.4 Eyegate Pharmaceuticals Non-infectious Anterior Uveitis Treatment Sales and Revenue in Global (2018-2023)
7.6.5 Eyegate Pharmaceuticals Key News & Latest Developments
7.7 Regeneron Pharmaceuticals
7.7.1 Regeneron Pharmaceuticals Company Summary
7.7.2 Regeneron Pharmaceuticals Business Overview
7.7.3 Regeneron Pharmaceuticals Non-infectious Anterior Uveitis Treatment Major Product Offerings
7.7.4 Regeneron Pharmaceuticals Non-infectious Anterior Uveitis Treatment Sales and Revenue in Global (2018-2023)
7.7.5 Regeneron Pharmaceuticals Key News & Latest Developments
7.8 Eyepoint pharmaceuticals
7.8.1 Eyepoint pharmaceuticals Company Summary
7.8.2 Eyepoint pharmaceuticals Business Overview
7.8.3 Eyepoint pharmaceuticals Non-infectious Anterior Uveitis Treatment Major Product Offerings
7.8.4 Eyepoint pharmaceuticals Non-infectious Anterior Uveitis Treatment Sales and Revenue in Global (2018-2023)
7.8.5 Eyepoint pharmaceuticals Key News & Latest Developments
7.9 Alimera Sciences
7.9.1 Alimera Sciences Company Summary
7.9.2 Alimera Sciences Business Overview
7.9.3 Alimera Sciences Non-infectious Anterior Uveitis Treatment Major Product Offerings
7.9.4 Alimera Sciences Non-infectious Anterior Uveitis Treatment Sales and Revenue in Global (2018-2023)
7.9.5 Alimera Sciences Key News & Latest Developments
8 Global Non-infectious Anterior Uveitis Treatment Production Capacity, Analysis
8.1 Global Non-infectious Anterior Uveitis Treatment Production Capacity, 2018-2029
8.2 Non-infectious Anterior Uveitis Treatment Production Capacity of Key Manufacturers in Global Market
8.3 Global Non-infectious Anterior Uveitis Treatment Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Non-infectious Anterior Uveitis Treatment Supply Chain Analysis
10.1 Non-infectious Anterior Uveitis Treatment Industry Value Chain
10.2 Non-infectious Anterior Uveitis Treatment Upstream Market
10.3 Non-infectious Anterior Uveitis Treatment Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Non-infectious Anterior Uveitis Treatment Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Non-infectious Anterior Uveitis Treatment in Global Market
Table 2. Top Non-infectious Anterior Uveitis Treatment Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Non-infectious Anterior Uveitis Treatment Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Non-infectious Anterior Uveitis Treatment Revenue Share by Companies, 2018-2023
Table 5. Global Non-infectious Anterior Uveitis Treatment Sales by Companies, (K Units), 2018-2023
Table 6. Global Non-infectious Anterior Uveitis Treatment Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Non-infectious Anterior Uveitis Treatment Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Non-infectious Anterior Uveitis Treatment Product Type
Table 9. List of Global Tier 1 Non-infectious Anterior Uveitis Treatment Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Non-infectious Anterior Uveitis Treatment Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Non-infectious Anterior Uveitis Treatment Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Non-infectious Anterior Uveitis Treatment Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Non-infectious Anterior Uveitis Treatment Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Non-infectious Anterior Uveitis Treatment Sales (K Units), 2018-2023
Table 15. By Type - Global Non-infectious Anterior Uveitis Treatment Sales (K Units), 2024-2029
Table 16. By Application – Global Non-infectious Anterior Uveitis Treatment Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Non-infectious Anterior Uveitis Treatment Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Non-infectious Anterior Uveitis Treatment Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Non-infectious Anterior Uveitis Treatment Sales (K Units), 2018-2023
Table 20. By Application - Global Non-infectious Anterior Uveitis Treatment Sales (K Units), 2024-2029
Table 21. By Region – Global Non-infectious Anterior Uveitis Treatment Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Non-infectious Anterior Uveitis Treatment Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Non-infectious Anterior Uveitis Treatment Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Non-infectious Anterior Uveitis Treatment Sales (K Units), 2018-2023
Table 25. By Region - Global Non-infectious Anterior Uveitis Treatment Sales (K Units), 2024-2029
Table 26. By Country - North America Non-infectious Anterior Uveitis Treatment Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Non-infectious Anterior Uveitis Treatment Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Non-infectious Anterior Uveitis Treatment Sales, (K Units), 2018-2023
Table 29. By Country - North America Non-infectious Anterior Uveitis Treatment Sales, (K Units), 2024-2029
Table 30. By Country - Europe Non-infectious Anterior Uveitis Treatment Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Non-infectious Anterior Uveitis Treatment Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Non-infectious Anterior Uveitis Treatment Sales, (K Units), 2018-2023
Table 33. By Country - Europe Non-infectious Anterior Uveitis Treatment Sales, (K Units), 2024-2029
Table 34. By Region - Asia Non-infectious Anterior Uveitis Treatment Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Non-infectious Anterior Uveitis Treatment Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Non-infectious Anterior Uveitis Treatment Sales, (K Units), 2018-2023
Table 37. By Region - Asia Non-infectious Anterior Uveitis Treatment Sales, (K Units), 2024-2029
Table 38. By Country - South America Non-infectious Anterior Uveitis Treatment Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Non-infectious Anterior Uveitis Treatment Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Non-infectious Anterior Uveitis Treatment Sales, (K Units), 2018-2023
Table 41. By Country - South America Non-infectious Anterior Uveitis Treatment Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Non-infectious Anterior Uveitis Treatment Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Non-infectious Anterior Uveitis Treatment Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Non-infectious Anterior Uveitis Treatment Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Non-infectious Anterior Uveitis Treatment Sales, (K Units), 2024-2029
Table 46. Bausch & Lomb Company Summary
Table 47. Bausch & Lomb Non-infectious Anterior Uveitis Treatment Product Offerings
Table 48. Bausch & Lomb Non-infectious Anterior Uveitis Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Bausch & Lomb Key News & Latest Developments
Table 50. Santen Pharmaceutical Company Summary
Table 51. Santen Pharmaceutical Non-infectious Anterior Uveitis Treatment Product Offerings
Table 52. Santen Pharmaceutical Non-infectious Anterior Uveitis Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Santen Pharmaceutical Key News & Latest Developments
Table 54. AbbVie Company Summary
Table 55. AbbVie Non-infectious Anterior Uveitis Treatment Product Offerings
Table 56. AbbVie Non-infectious Anterior Uveitis Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. AbbVie Key News & Latest Developments
Table 58. OKYO Company Summary
Table 59. OKYO Non-infectious Anterior Uveitis Treatment Product Offerings
Table 60. OKYO Non-infectious Anterior Uveitis Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. OKYO Key News & Latest Developments
Table 62. Novartis Company Summary
Table 63. Novartis Non-infectious Anterior Uveitis Treatment Product Offerings
Table 64. Novartis Non-infectious Anterior Uveitis Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Novartis Key News & Latest Developments
Table 66. Eyegate Pharmaceuticals Company Summary
Table 67. Eyegate Pharmaceuticals Non-infectious Anterior Uveitis Treatment Product Offerings
Table 68. Eyegate Pharmaceuticals Non-infectious Anterior Uveitis Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Eyegate Pharmaceuticals Key News & Latest Developments
Table 70. Regeneron Pharmaceuticals Company Summary
Table 71. Regeneron Pharmaceuticals Non-infectious Anterior Uveitis Treatment Product Offerings
Table 72. Regeneron Pharmaceuticals Non-infectious Anterior Uveitis Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Regeneron Pharmaceuticals Key News & Latest Developments
Table 74. Eyepoint pharmaceuticals Company Summary
Table 75. Eyepoint pharmaceuticals Non-infectious Anterior Uveitis Treatment Product Offerings
Table 76. Eyepoint pharmaceuticals Non-infectious Anterior Uveitis Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. Eyepoint pharmaceuticals Key News & Latest Developments
Table 78. Alimera Sciences Company Summary
Table 79. Alimera Sciences Non-infectious Anterior Uveitis Treatment Product Offerings
Table 80. Alimera Sciences Non-infectious Anterior Uveitis Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. Alimera Sciences Key News & Latest Developments
Table 82. Non-infectious Anterior Uveitis Treatment Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 83. Global Non-infectious Anterior Uveitis Treatment Capacity Market Share of Key Manufacturers, 2021-2023
Table 84. Global Non-infectious Anterior Uveitis Treatment Production by Region, 2018-2023 (K Units)
Table 85. Global Non-infectious Anterior Uveitis Treatment Production by Region, 2024-2029 (K Units)
Table 86. Non-infectious Anterior Uveitis Treatment Market Opportunities & Trends in Global Market
Table 87. Non-infectious Anterior Uveitis Treatment Market Drivers in Global Market
Table 88. Non-infectious Anterior Uveitis Treatment Market Restraints in Global Market
Table 89. Non-infectious Anterior Uveitis Treatment Raw Materials
Table 90. Non-infectious Anterior Uveitis Treatment Raw Materials Suppliers in Global Market
Table 91. Typical Non-infectious Anterior Uveitis Treatment Downstream
Table 92. Non-infectious Anterior Uveitis Treatment Downstream Clients in Global Market
Table 93. Non-infectious Anterior Uveitis Treatment Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Non-infectious Anterior Uveitis Treatment Segment by Type in 2022
Figure 2. Non-infectious Anterior Uveitis Treatment Segment by Application in 2022
Figure 3. Global Non-infectious Anterior Uveitis Treatment Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Non-infectious Anterior Uveitis Treatment Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Non-infectious Anterior Uveitis Treatment Revenue, 2018-2029 (US$, Mn)
Figure 7. Non-infectious Anterior Uveitis Treatment Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Non-infectious Anterior Uveitis Treatment Revenue in 2022
Figure 9. By Type - Global Non-infectious Anterior Uveitis Treatment Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Non-infectious Anterior Uveitis Treatment Revenue Market Share, 2018-2029
Figure 11. By Type - Global Non-infectious Anterior Uveitis Treatment Sales Market Share, 2018-2029
Figure 12. By Type - Global Non-infectious Anterior Uveitis Treatment Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Non-infectious Anterior Uveitis Treatment Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Non-infectious Anterior Uveitis Treatment Revenue Market Share, 2018-2029
Figure 15. By Application - Global Non-infectious Anterior Uveitis Treatment Sales Market Share, 2018-2029
Figure 16. By Application - Global Non-infectious Anterior Uveitis Treatment Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Non-infectious Anterior Uveitis Treatment Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Non-infectious Anterior Uveitis Treatment Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Non-infectious Anterior Uveitis Treatment Revenue Market Share, 2018-2029
Figure 20. By Region - Global Non-infectious Anterior Uveitis Treatment Sales Market Share, 2018-2029
Figure 21. By Country - North America Non-infectious Anterior Uveitis Treatment Revenue Market Share, 2018-2029
Figure 22. By Country - North America Non-infectious Anterior Uveitis Treatment Sales Market Share, 2018-2029
Figure 23. US Non-infectious Anterior Uveitis Treatment Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Non-infectious Anterior Uveitis Treatment Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Non-infectious Anterior Uveitis Treatment Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Non-infectious Anterior Uveitis Treatment Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Non-infectious Anterior Uveitis Treatment Sales Market Share, 2018-2029
Figure 28. Germany Non-infectious Anterior Uveitis Treatment Revenue, (US$, Mn), 2018-2029
Figure 29. France Non-infectious Anterior Uveitis Treatment Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Non-infectious Anterior Uveitis Treatment Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Non-infectious Anterior Uveitis Treatment Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Non-infectious Anterior Uveitis Treatment Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Non-infectious Anterior Uveitis Treatment Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Non-infectious Anterior Uveitis Treatment Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Non-infectious Anterior Uveitis Treatment Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Non-infectious Anterior Uveitis Treatment Sales Market Share, 2018-2029
Figure 37. China Non-infectious Anterior Uveitis Treatment Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Non-infectious Anterior Uveitis Treatment Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Non-infectious Anterior Uveitis Treatment Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Non-infectious Anterior Uveitis Treatment Revenue, (US$, Mn), 2018-2029
Figure 41. India Non-infectious Anterior Uveitis Treatment Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Non-infectious Anterior Uveitis Treatment Revenue Market Share, 2018-2029
Figure 43. By Country - South America Non-infectious Anterior Uveitis Treatment Sales Market Share, 2018-2029
Figure 44. Brazil Non-infectious Anterior Uveitis Treatment Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Non-infectious Anterior Uveitis Treatment Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Non-infectious Anterior Uveitis Treatment Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Non-infectious Anterior Uveitis Treatment Sales Market Share, 2018-2029
Figure 48. Turkey Non-infectious Anterior Uveitis Treatment Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Non-infectious Anterior Uveitis Treatment Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Non-infectious Anterior Uveitis Treatment Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Non-infectious Anterior Uveitis Treatment Revenue, (US$, Mn), 2018-2029
Figure 52. Global Non-infectious Anterior Uveitis Treatment Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Non-infectious Anterior Uveitis Treatment by Region, 2022 VS 2029
Figure 54. Non-infectious Anterior Uveitis Treatment Industry Value Chain
Figure 55. Marketing Channels

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 非感染性前部ぶどう膜炎治療薬の世界市場見通し2023年-2029年(Non-infectious Anterior Uveitis Treatment Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

非感染性前部ぶどう膜炎治療薬の世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp